Commentary
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer
-
* Corresponding author: Mads H Andersen mha@cancer.dk
Journal of Translational Medicine 2006, 4:38 doi:10.1186/1479-5876-4-38
No comments have yet been made on this article.